Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting.
CONCLUSION: This study suggests 2 mg lorazepam may be an optimal LCT dose, given significant response to most catatonic signs thereby ensuring accurate detection and preventing misinterpretation of response. It offers future studies direction for standardizing lorazepam dosing schedules for catatonia management and exploring neurobiological underpinnings for individual catatonic signs that may be potentially different, given these findings.
PMID: 33124447 [PubMed - as supplied by publisher]
Source: The Australian and New Zealand Journal of Psychiatry - Category: Psychiatry Authors: Suchandra HH, Reddi VSK, Aandi Subramaniyam B, Muliyala KP Tags: Aust N Z J Psychiatry Source Type: research
More News: Ativan | Australia Health | Brain | Emergency Medicine | India Health | Lorazepam | Neurology | New Zealand Health | Psychiatry | Study